23andMe Data Breach Larger Than Previously Reported
Is the genetic testing company trying to avoid liability?
The numbers for the genetic testing company’s October data breach are much larger than previously reported, and now the company might be trying to shield itself from class action lawsuits.
You may also be interested in...
This week, the FDA told providers not to use Synovo’s total hip resurfacing system because it’s been modified since it was cleared; 23andMe is facing another class action suit related to its October data breach; and North Carolina Rep. Gregory Murphy asked FDA Commissioner Robert Califf to avoid a one-size-fits-all approach in AI regulation.
The Biden administration issued an executive order to protect American data privacy. On the same day, the Senate HELP committee released its report on health data privacy with suggestions to update HIPAA for a modern healthcare world.
Systems from Change Healthcare are experiencing disruptions for the seventh day in a row after a ransomware attack on parent company UnitedHealth Group.